Your session is about to expire
← Back to Search
Induction Venetoclax for Follicular Lymphoma (PrE0403 Trial)
PrE0403 Trial Summary
This trial is studying the side effects of adding venetoclax to obinutuzumab and bendamustine in treating patients with follicular lymphoma.
- Follicular Lymphoma
- Non-Hodgkin's Lymphoma
PrE0403 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPrE0403 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2023 Phase 2 trial • 56 Patients • NCT03113422PrE0403 Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What potential dangers are associated with Induction Venetoclax use?
"Although Induction Venetoclax has not yet been clinically proven to be effective, it is considered moderately safe due to some supporting data; thus, Power assigned the drug a score of 2."
Are there any participating institutions currently executing this research project in the local vicinity?
"Ten trial sites are participating in this medical research. Participants can find locations at the Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Washington University School of Medicine, and Mayo Clinic Rochester among others."
How many participants are currently undergoing the research protocol?
"At present, this medical trial has concluded its recruitment process. First appearing on December 27th 2017 and last updated July 13th 2022, it is no longer seeking participants for the study. However, there are currently 1751 trials researching lymphoma and 219 other studies related to induction venetoclax that remain open to new enrolments."
Are there any prior experiments which have utilized Induction Venetoclax?
"Currently, 28 Phase 3 trials of Induction Venetoclax are ongoing and encompass 219 individual studies. Although Boston is the epicentre for such research, there are an impressive 7198 locations worldwide conducting this type of trial."
Is this experiment open to new participants at present?
"The clinicaltrials.gov database does not indicate that this research project is currently recruiting patients, despite its initial posting on December 27th 2017 and last update on July 13th 2022. However, there are 1970 other studies actively searching for participants right now."
Share this study with friends
Copy Link
Messenger